These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1788763)
21. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery]. Loeliger EA Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2222-3. PubMed ID: 8247170 [No Abstract] [Full Text] [Related]
25. Left ventricular function after coronary bypass surgery. Bourassa MG Cardiovasc Clin; 1991; 21(2):227-37. PubMed ID: 2044090 [No Abstract] [Full Text] [Related]
26. Interpretation of Dutch BOA trial. Dutch Bypass Oral anticoagulants or Aspirin study group. Algra A; Tangelder MJ; Lawson JA; Eikelboom BC Lancet; 2000 Apr; 355(9210):1186-7. PubMed ID: 10791406 [No Abstract] [Full Text] [Related]
27. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery]. Urquhart J; Thijssen H; Struijker Boudier HA Ned Tijdschr Geneeskd; 1994 Jan; 138(1):46-7. PubMed ID: 8289961 [No Abstract] [Full Text] [Related]
29. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent. Zimmermann N; Gams E; Hohlfeld T Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350 [TBL] [Abstract][Full Text] [Related]
30. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery]. Verheugt FW Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2223. PubMed ID: 8247171 [No Abstract] [Full Text] [Related]
31. [Preventive drug therapy following coronary bypass surgery or PTCA]. Lechleitner P; Genser N; Dienstl F Wien Med Wochenschr; 1990 Jun; 140(10-11):277-8, 281. PubMed ID: 2368420 [TBL] [Abstract][Full Text] [Related]
32. Future implications of current trends in bypass surgery. Lytle BW; Cosgrove D; Loop FD Cardiovasc Clin; 1991; 21(2):265-78. PubMed ID: 2044094 [No Abstract] [Full Text] [Related]
33. [Prevention of venous thrombosis and embolism of the pulmonary artery in the postoperative period (review of the literature)]. Pavlovskiĭ DP Khirurgiia (Mosk); 1988 Dec; (12):148-51. PubMed ID: 3070125 [No Abstract] [Full Text] [Related]
34. [Antithrombotic agents in coronary bypass surgery in The Netherlands]. Galema TW; Verheugt FW Ned Tijdschr Geneeskd; 1990 Aug; 134(34):1632-6. PubMed ID: 2215703 [No Abstract] [Full Text] [Related]
36. Off-pump coronary bypass surgery: another brick in the wall of reduced graft patency. Parolari A; Tremoli E; Biglioli P; Alamanni F Ann Thorac Surg; 2009 Feb; 87(2):675-6; author reply 676. PubMed ID: 19161824 [No Abstract] [Full Text] [Related]
37. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery]. Visser J Ned Tijdschr Geneeskd; 1994 Feb; 138(8):426-7. PubMed ID: 8127387 [No Abstract] [Full Text] [Related]
38. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery]. Houben JJ; Nicolai G Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2225; author reply 2225-6. PubMed ID: 8247173 [No Abstract] [Full Text] [Related]